Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Red Blood Cell Membrane Panel, Next-Generation Sequencing Mayo Clinic Laboratories Mayo Clinic United States | 19 | 14 |
|
Red Blood Cell Enzyme Panel, Next-Generation Sequencing Mayo Clinic Laboratories Mayo Clinic United States | 19 | 17 |
|
Congenital Dyserythropoietic Anemia Panel, Next-Generation Sequencing Mayo Clinic Laboratories Mayo Clinic United States | 6 | 10 |
|
UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing Mayo Clinic Laboratories Mayo Clinic United States | 11 | 1 |
|
Gilbert syndrome (UGT1A1 gene) Molecular Genetics and Cytogenetics, Clinical Laboratory Service RED DE SALUD UC CHRISTUS Chile | 1 | 3 |
|
UGT1A1 genotyping for Gilbert Syndrome Genetic Services Laboratory University of Chicago United States | 1 | 1 |
|
UGT1A1 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 5 | 1 |
|
UGT1A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
Invitae Pharmacogenomics Panel Invitae United States | 43 | 37 |
|
Invitae Crigler Najjar and Gilbert Syndrome Test Invitae United States | 5 | 1 |
|
Invitae United States | 210 | 134 |
|
Congenital Anomalies of the Gastrointestinal Tract Panel PreventionGenetics United States | 297 | 180 |
|
PreventionGenetics United States | 130 | 69 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
IU Genetic Testing Laboratories Indiana University School of Medicine United States | 1 | 1 |
|
IU Genetic Testing Laboratories Indiana University School of Medicine United States | 1 | 1 |
|
Crigler-Najjar Syndrome and Gilbert Syndrome via the UGT1A1 Gene PreventionGenetics United States | 3 | 1 |
|
UGT1A1. Detection of the allele A(TA)7TAA in promotor region by real time PCR IGENOMIX Spain | 1 | 1 |
|
IGENOMIX Spain | 1 | 1 |
|
Cholestasis panel. NGS panel of 46 genes. Genologica Medica Spain | 88 | 46 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.